Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Shandong Weigao Medical Polymer Co. (SHWGF) had Revenue of $1.87B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$1.87B
Net Income	$282.87M
Cost of Goods Sold	$930.66M
Gross Profit	$938.66M
Operating Expenses	$1.51B
Operating Income	$363.23M
Non-Operating Income/Expense	$-28.47M
Pre-Tax Income	$334.77M
Normalized Pre-Tax Income	$324.66M
Income after Taxes	$291.30M
Income from Continuous Operations	$291.30M
Consolidated Net Income/Loss	$291.30M
Normalized Income after Taxes	$279.89M
EBIT	$363.23M
EBITDA	$492.06M
Weighted-Average Shares Outstanding (Basic)	4.51B
Weighted-Average Shares Outstanding (Diluted)	4.52B
Earnings per Share (EPS) (Basic)	$0.06
Earnings per Share (EPS) (Diluted)	$0.06
Balance Sheet Financials
Current Assets	$2.63B
Property, Plant, and Equipment	$920.21M
Long-Term Assets	$2.12B
Total Assets	$4.76B
Current Liabilities	$1.07B
Long-Term Debt	$211.29M
Long-Term Liabilities	$296.09M
Total Liabilities	$1.37B
Common Equity	$3.39B
Tangible Shareholders Equity	$2.65B
Shareholders Equity	$3.39B
Common Shares Outstanding	4.57B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$395.43M
Cash Flow from Investing Activities	$-196.21M
Cash Flow from Financial Activities	$-304.91M
Beginning Cash	$780.12M
End Cash	$677.88M
Increase/Decrease in Cash	$-102.24M
Stock-Based Compensation	$7.84M
Common Stock Dividends Paid	$-103.52M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.46
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.17
Gross Margin	50.21%
Operating Margin	19.43%
EBIT Margin	19.43%
EBITDA Margin	26.32%
Pre-Tax Profit Margin	17.91%
Profit Margin	15.13%
Free Cash Flow	$351.27M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.39
Inventory Turnover	2.64
Receiveable Turnover	1.79
Days Sales in Receivables	204.39
Return on Equity	8.59%
Return on Tangible Equity	10.99%
Return on Assets	6.12%
Return on Investments	8.09%
Book Value Per Share	$0.74
Free Cash Flow per Share	$0.08
Operating Cash Flow per Share	$0.09

Data from Zacks Investment Research, Inc.